partner treating kids news report

Akili Expands Prescription Digital Therapeutics Portfolio with TALi Partnership

Reading now: 242

August 18, 2021Akili Interactive, the developer behind the first FDA-approved game-based prescription treatment for ADHD, announced this week that it is partnering with TALi Digital, an Australian-based digital health company, to license its attention-improving game software in the U.S.

provided FDA approval.Under the deal, the two companies will work together to execute clinical trials of TALi’s video game-based technology — designed to screen for and improve early childhood attention impairments — in pediatric ADHD and pursue FDA regulatory clearance.

Upon securing FDA approval, Akili will lead the treatment’s U.S. commercialization and roll-out.The agreement complements Akili’s own flagship product, EndeavorRx, a game-based digital.

The website is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.